CHOLESTEROL AND ATHEROMA LIPIDS ACTIVATE COMPLEMENT AND STIMULATE GRANULOCYTES - A POSSIBLE MECHANISM FOR AMPLIFICATION OF ISCHEMIC-INJURY IN ATHEROSCLEROTIC STATES
- 1 January 1981
- journal article
- research article
- Vol. 98 (1) , 68-77
Abstract
Studies in experimental myocardial infarction have suggested that PMN [granulocytes] and plasma C [complement] might interact to intensity ischemic injury. From the finding of large amounts of activated C (specifically C5a) in the plasma of a patient with severe, ulcerating atherosclerosis and the cholesterol embolization syndrome, crystalline cholesterol was postulated to activate C and thereby amplify infarctive tissue damage. On simple incubation, crystalline cholesterol, and lipids from atheromata, activated plasma C; such plasma then potently aggregated normal PMN and provokedthem to damage cultured endothelial cells in vitro. The active principle in cholesterol-incubated plasma was a molecular weight and antigenicity consistent with C5a (or C5a[desarginine]). Optimal activation required the presence of Ig and an intact classical C pathway. Exposure of plasma to crystalline cholesterol by ulceration of, or hemorrhage into, atherosclerotic plaques might therefore activate C in vivo, promoting further ischemic damage by causing leukostatic-leukoembolic compromise of small vessels downstream from the site of activation.This publication has 14 references indexed in Scilit:
- Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.Journal of Clinical Investigation, 1979
- Immunoglobulin G independent activation of the classical complement pathway by monosodium urate crystals.Journal of Clinical Investigation, 1979
- Spontaneously occurring angiotoxic derivatives of cholesterolThe American Journal of Clinical Nutrition, 1979
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- Granulocyte-complement interaction. A beneficial antimicrobial mechanism that can cause diseaseArchives of internal medicine (1960), 1978
- COMPLEMENT ACTIVATION AND PULMONARY LEUKOSTASIS DURING NYLON FIBER FILTRATION LEUKAPHERESIS1978
- Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.Journal of Clinical Investigation, 1977
- Cholesterol-Dependent Human Complement Activation Resulting in Damage to Liposomal Model MembranesThe Journal of Immunology, 1977
- The Nitroblue Tetrazolium Test and Acute Myocardial InfarctionAnnals of Internal Medicine, 1973
- ARTERIAL OCCLUSIONS PRODUCED BY EMBOLI FROM ERODED AORTIC ATHEROMATOUS PLAQUES1945